Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Christer Janson,1 Georgios Stratelis,1,2 Anna Miller-Larsson,3 Tim W Harrison,4 Kjell Larsson5 1Respiratory, Allergy and Sleep Research Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; 2Respiratory, Inflammation and Autoimmunity, AstraZeneca Nordic, Södert&aum...

Full description

Bibliographic Details
Main Authors: Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:International Journal of COPD
Subjects:
COPD
pneumonia
inhaled corticosteroids
budesonide
fluticasone
Online Access:https://www.dovepress.com/scientific-rationale-for-the-possible-inhaled-corticosteroid-intraclas-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/scientific-rationale-for-the-possible-inhaled-corticosteroid-intraclas-peer-reviewed-article-COPD

Similar Items